Timothy Churchill
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Disorders of the pulmonic valve (PV) receive considerably less attention than other forms of valvular heart disease. Due to the dramatically improved survival of children with congenital heart disease over the last 5 decades, there has been a steady increase in the prevalence of adults with congenital heart disease, which necessitates that clinicians become familiar with the anatomy and the evaluation of right ventricular outflow tract and PV anomalies. A multimodality imaging approach using echocardiography, cardiac computed tomography, and magnetic resonance imaging is essential for a comprehensive evaluation of the anatomy and function of the right ventricular outflow tract, PV, and supravalvular region. As clinical presentation is often insidious with nonspecific symptoms, yet morbidity and mortality associated with severe untreated PV disease are significant, a high index of suspicion coupled with appropriate use of imaging techniques is critical in facilitating timely diagnosis and treatment. In this review, we aim to present a comprehensive approach to the diagnosis of PV disease and associated right ventricular outflow tract or supravalvular pulmonary stenosis, including optimal use of multimodality imaging to facilitate timely diagnosis, optimize therapeutic strategies, enhance postprocedural surveillance, and ultimately improve patient outcomes.
Year:
2025
The athlete’s heart, formally introduced by Henschen and Darling in 1899 through observations of cardiac enlargement in endurance athletes, has evolved from a clinical curiosity to a recognized physiological adaptation. Even before this naming, similar constructs such as the soldier’s heart in military recruits and the runner’s heart in distance athletes suggested early observations of exercise-associated cardiac remodeling—often pathologized or mischaracterized. Today, this phenomenon is understood as exercise-induced cardiac remodeling, comprising structural, functional, and electrical changes that support the demands of sustained athletic performance. This compendium review examines the full spectrum of exercise-induced cardiac remodeling. We begin by tracing the historical context of how the athlete’s heart was discovered and progressively understood. We then explore the morphological and functional adaptations that arise with different exercise modalities, distinguishing between endurance and resistance training effects. The review further investigates the molecular and genetic underpinnings of exercise-induced cardiac remodeling, leveraging data from both human subjects and experimental animal models. We also address the clinical challenges posed by exercise-induced cardiac remodeling, including its phenotypic overlap with cardiomyopathies, such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathy. These overlaps complicate athlete evaluation and risk stratification, particularly in preparticipation screening and return-to-play decisions. Finally, we explore concerns regarding the long-term effects of high-volume endurance training, including potential maladaptation. Together, this review offers a synthesis of current knowledge and a window into the athlete’s heart. By integrating perspectives from history, physiology, molecular biology, and clinical cardiology, we aim to highlight the distinctiveness of this phenotype and why it warrants focused scientific inquiry.
Year:
2025
Year:
2025
Aims The shift in mitral stenosis (MS) aetiology from rheumatic to calcific valve disease complicates distinguishing valve-related from myocardial-driven haemodynamic abnormalities. This study examines how left-heart myopathy influences flow velocity-based echocardiographic MS severity assessment and evaluates haemodynamic changes following mitral valve (MV) intervention at rest and during exercise. Methods and results The CircAdapt biophysical model was used to create a virtual cohort with varying MS severity, left ventricular (LV) compliance, and left atrial (LA) function. Mean gradient (MG) was evaluated alongside left-heart pressures at rest and during exercise. To study acute haemodynamic effects of MV intervention, the mitral valve’s effective orifice area was restored to 5.9 cm². MG showed variation of 1 mmHg attributable to left-heart myopathy. Following virtual MV intervention for clinically significant MS, mean left atrial pressure (mLAP) decreased by 50% in patients with preserved myocardial function but remained elevated in those with LV and LA dysfunction due to persistently elevated LV end-diastolic pressure, resulting in persistently impaired exercise capacity. Conclusion Virtual patient cohorts suggest that MV intervention reduces MG but may not normalize mLAP in patients with impaired LV and LA function. Persistent myocardial dysfunction may limit both symptomatic and exercise capacity improvement, despite successful intervention. As percutaneous treatment options expand, distinguishing myocardial from valve-driven abnormalities is essential for accurate assessment, patient selection, and optimizing outcomes.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Collaborators (18)
Kristina Haugaa
Professor
University of Oslo
James Guseh
Massachusetts General Hospital
Haobo Li
Assistant Professor
Harvard University
Flavio D’Ascenzi
University of Siena
Mahnaz Maddah
Director, Machine Learning for Health
Broad Institute
Thijs Eijsvogels
Associate Professor
Radboud University Medical Center
Gitte van den Acker
University of Maastricht
Joost Lumens
Professor at Maastricht University
University of Maastricht
Kristen Kucera
Professor
University of North Carolina at Chapel Hill
Jonathan Drezner
Professor
University of Washington
Aaron Baggish
Professor
University of Lausanne
Ada C. Stefanescu Schmidt
Harvard University
Bradley Petek
Oregon Health & Science University
James Pirruccello
University of California, San Francisco
Elizabeth Dineen
Assistant Professor
Mayo Clinic Florida
Luisa Mestroni
Professor of Medicine
University of Colorado Anschutz Medical Campus
Kimberly Harmon
Professor
University of Washington
Jonathan H. Kim
Sports Cardiology
Emory University
Make your next move.
Prepare your application
Review drafts before you send them.